1) recombinant human pancreatic kallikrein
重组人胰激肽原酶
2) pancreatic kininogenase
胰激肽原酶
1.
Clinical observation of pancreatic kininogenase for treating 78 cases of diabetic nephropathy;
胰激肽原酶治疗78例糖尿病性肾病临床观察
2.
Objective To improve the purity of pancreatic kininogenase.
目的提高胰激肽原酶的纯度。
3.
OBJECTIVE To investigate the effects of carbohydrates on the stabilization of pancreatic kininogenase(PKase)under various conditions.
目的研究不同条件下糖类对胰激肽原酶活性的稳定作用。
3) kallidinogenase
胰激肽原酶
1.
Treatment of diabetic retinopathy by combination of kallidinogenase and compound Danshen dripping pills;
胰激肽原酶与复方丹参滴丸联合治疗糖尿病视网膜病变的临床观察
2.
Kallidinogenase plus Radix Astragali for Diabetic Nephropathy:Observation of Curative Efficacy;
胰激肽原酶联合黄芪治疗糖尿病肾病的临床观察
3.
Clinical Research on Senile Diabetic Nephropathy Treated with Kallidinogenase;
胰激肽原酶治疗老年糖尿病肾病的临床研究
4) recombinant human proinsulin C-peptide
重组人源胰岛素原C肽
1.
Cloning ,expression and purification of recombinant human proinsulin C-peptide in E.coli;
重组人源胰岛素原C肽在大肠杆菌中的克隆、表达与纯化(英文)
5) Yikai
怡开(胰激肽原酶)
6) pancreatic kininogenase tablets
胰激肽原酶片
1.
Therapeutic effect of Huangqi injection and pancreatic kininogenase tablets on the early stage diabetic nephropathy;
黄芪注射液与胰激肽原酶片对早期糖尿病肾病疗效观察
2.
Objective:To evaluate the efficacy and safety of the pancreatic kininogenase tablets in treating early stage diabetic nephropathy.
目的:评价胰激肽原酶片治疗早期糖尿病肾病患者的疗效和安全性。
补充资料：胰激肽原酶
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：生化药。
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：生化药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条